S&S Healthcare Holding Ltd.
TTPEX:419845.00
TWD
-2.15
(-4.56%)
ISIN
TW0004198007
Return %
Stock
S&P 500
1Y
19.21
14.20
3Y
84.80
81.12
5Y
39.10
68.34
Capital Structure
TWD
•
in mil. unless spec.Working Capital
TWD
•
in mil. unless spec.Growth Rates
TWD
•
in mil. unless spec.Quarterly Revenue
TWD
•
in mil. unless spec.Quarterly Earnings Per Share
TWD
•
in mil. unless spec.Quarterly Dividends Per Share
TWD
•
in mil. unless spec.Company Description
- CEO
- Pei Lin Lee
- Full Time Employees
- 200
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- No. 85 Xinhu 1st Road Taipei TP Taiwan 114
- IPO Date
- Dec 23, 2014
- Website
- swissray.com
- Similar Companies
- Business
- S&S Healthcare Holding Ltd. is a Taiwan-based investment holding company primarily engaged in the research and development, production, sales, and agency of digital X-ray diagnostic imaging equipment and bone density testing equipment. The company also provides installation, maintenance, upgrade services for these products globally, including maintenance services for 1.5 Tesla magnetic resonance imaging (MRI) devices. Its core product portfolio includes digital X-ray machines, bone density equipment, and MRI maintenance solutions. The company operates across major markets including North America, Europe, and Asia. Founded in 1988 and headquartered in Taiwan, S&S Healthcare positions itself in the healthcare equipment industry, serving hospitals, clinics, and medical service providers with advanced medical imaging technology and related service offerings. In the last 1-2 years, S&S Healthcare has focused on expanding its product lines to include personal protective equipment (PPE) and developing equipment for long-term care services. It has initiated expansion into the veterinary healthcare business and pursued integration of physical and virtual distribution channels to enhance market reach. The company has also expanded its network of domestic and international distributors and introduced new sales models to strengthen its competitive positioning. Recent strategies emphasize multi-brand approaches with niche brands focusing on e-commerce, alongside solidifying cooperation with pharmacy channels and ophthalmology clinics to increase sales and profitability. Additionally, the company underwent a significant transformation in its business approach by rebranding as Reflect Health in October 2025 to reflect its evolution from a traditional third-party administrator (TPA) to a Benefits Hub. This new identity offers a centralized platform that integrates administration, network access, and marketplace services tailored for self-funded insurance plans. Reflect Health provides tailored plan management, access to premium national and specialty networks, and a curated marketplace of cost containment and member experience solutions, leveraging proprietary technology and over 100 TPA affiliations nationwide. This strategic shift is supported by a major growth investment from private equity firm Lovell Minnick Partners, aiming to accelerate operational efficiency, expand solution offerings, and advance market presence in the self-funded healthcare sector. S&S Healthcare operates broadly in the health care equipment and healthcare services industries, targeting hospitals, clinics, program managers, TPAs, brokers, and employers with mid-sized to large health plans. Its international footprint spans North America, Europe, and Asia, with a focus on connecting healthcare providers and insurers through innovative technology and service platforms. The company was founded in 1988 and is headquartered in Taiwan. Its recent corporate developments include acquisitions, new executive appointments, and strategic partnerships to enhance governance and growth capabilities. Overall, S&S Healthcare Holding Ltd. combines manufacturing and servicing of advanced medical imaging devices with a newly expanded role as a technology-driven benefits administration hub, blending physical medical equipment with digital healthcare service innovations to meet evolving customer needs in global healthcare markets.